LSS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.154200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.200000E-02
Normal-vs-Stage2
2.876300E-02
Normal-vs-Stage3
1.139250E-01
Normal-vs-Stage4
2.746600E-01
Stage1-vs-Stage2
7.166000E-01
Stage1-vs-Stage3
4.219000E-01
Stage1-vs-Stage4
9.971800E-01
Stage2-vs-Stage3
5.918400E-01
Stage2-vs-Stage4
7.721400E-01
Stage3-vs-Stage4
6.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.518200E-01
Normal-vs-AfricanAmerican
3.943500E-02
Normal-vs-Asian
2.151000E-01
Caucasian-vs-AfricanAmerican
2.839600E-01
Caucasian-vs-Asian
7.318200E-01
AfricanAmerican-vs-Asian
9.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.738400E-02
Normal-vs-Female
6.383400E-01
Male-vs-Female
3.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.662160E-01
Normal-vs-Age(41-60Yrs)
2.591900E-02
Normal-vs-Age(61-80Yrs)
5.472400E-01
Normal-vs-Age(81-100Yrs)
3.089700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.043400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.884800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.821800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.661600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.252600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.302500E-02
Normal-vs-Daily Drinker
3.580900E-03
Normal-vs-Weekly Drinker
1.377610E-01
Normal-vs-Occasional Drinker
9.368000E-01
Normal-vs-Social Drinker
6.037600E-02
Non Drinker-vs-Daily Drinker
1.119440E-01
Non Drinker-vs-Weekly Drinker
4.243200E-01
Non Drinker-vs-Occasional Drinker
3.443600E-01
Non Drinker-vs-Social Drinker
5.593200E-01
Daily Drinker-vs-Weekly Drinker
3.863700E-02
Daily Drinker-vs-Occasional Drinker
2.418600E-01
Daily Drinker-vs-Social Drinker
4.266400E-02
Weekly Drinker-vs-Occasional Drinker
4.255800E-01
Weekly Drinker-vs-Social Drinker
8.070600E-01
Occasional Drinker-vs-Social Drinker
3.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.754400E-01
Normal-vs-Grade 2
7.743500E-02
Normal-vs-Grade 3
8.359900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.756000E-01
Grade 1-vs-Grade 3
3.011400E-01
Grade 1-vs-Grade 4
5.754400E-01
Grade 2-vs-Grade 3
3.896400E-01
Grade 2-vs-Grade 4
7.743500E-02
Grade 3-vs-Grade 4
8.359900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.664000E-02
Normal-vs-NonDiabetic
5.738800E-01
Diabetic-vs-NonDiabetic
1.987640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.109900E-02
Normal-vs-NoPancreatitis
5.035600E-01
Pancreatitis-vs-NoPancreatitis
8.147800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.267200E-01
Normal-vs-N1
3.079700E-02
N0-vs-N1
1.866830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.387370E-01
Normal-vs-TP53-NonMutant
7.349200E-01
TP53-Mutant-vs-TP53-NonMutant
3.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
